Specialty code 183500000X · Roseville, CA
NPI
1346640695
Since 2014
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1600 Eureka Rd
Roseville, CA, 95661
Phone (925) 890-0601
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$479K
2,968 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Alexander Fung prescribed most often to Medicare patients was Metformin Hcl Er (Metformin Hcl), with 317 prescriptions and refills. In total Alexander Fung wrote 2,968 Medicare prescriptions that cost $479K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-17.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Metformin Hcl Er Metformin Hcl | 317 | 1,018 | 128 | $3,124 |
| Atorvastatin Calcium Generic | 274 | 881 | 101 | $3,607 |
| Ozempic Semaglutide | 228 | 234 | 49 | $169K |
| Metformin Hcl Generic | 224 | 670 | 72 | $2,962 |
| Glipizide Generic | 205 | 678 | 78 | $2,587 |
| Jardiance Empagliflozin | 179 | 593 | 73 | $108K |
| Humulin N Insulin Nph Human Isophane | 133 | 402 | 59 | $24K |
| Lisinopril Generic | 133 | 408 | 49 | $1,719 |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 87 | 262 | 48 | $2,376 |
| Glipizide Er Glipizide | 80 | 263 | 31 | $3,140 |
| Losartan Potassium Generic | 71 | 237 | 29 | $979 |
| Insulin Glargine-Yfgn Generic | 70 | 202 | 40 | $8,498 |
| Pioglitazone Hcl Generic | 67 | 223 | 26 | $789 |
| Hydrochlorothiazide Generic | 66 | 220 | 23 | $777 |
| Humulin R Insulin Regular, Human | 65 | 193 | 28 | $13K |
Brand drugs: 876 claims; generic drugs: 1,871 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Alexander Fung were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.